Mr Mark Emberton holds the post of Reader in Interventional Oncological Surgery at the Institute of Urology, University College London and visiting Professor at Middlesex University, London.
He is also Clinical Director of the Clinical Effectiveness Unit at the Royal College of Surgeons of England. His clinical and research interests are focused mainly on diseases of the prostate gland, both benign and malignant.
His current interests in relation to LUTS include the evaluation of self-management.
In prostate cancer much of his activity is at present focussed on evaluating minimally invasive therapies for localised prostate cancer. He is also interested in the methodological aspects of clinical research, particularly on the use of alternatives to the randomised control trial in surgery.
He is involved in guideline production and appraisal and is interested in the formulation of evidence based management policies.
He is an active researcher, has lectured widely and has published over 100 peer reviewed articles in numerous scientific journals.
| Telephone | 020 7224 5089 |
| Fax | 020 7224 5593 |
